Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125100812 | 12510081 | 2 | F | 20160722 | 20160629 | 20160728 | EXP | GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-053501 | BRISTOL MYERS SQUIBB | GHAZALEH S. LATROGENIC CUSHING^S SYNDROME DUE TO INTERACTION BETWEEN RITONOVIR AND INJECTED INTRA ARTICULAR TRIAMCINOLONE. PAIN PRACTICE. 2016;16 (SUPPL. S1):147 | 46.00 | YR | M | Y | 0.00000 | 20160728 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125100812 | 12510081 | 1 | PS | TRIAMCINOLONE ACETONIDE. | TRIAMCINOLONE ACETONIDE | 1 | Intra-articular | UNK | U | U | 12041 | INJECTION | |||||||
| 125100812 | 12510081 | 2 | I | RITONAVIR. | RITONAVIR | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125100812 | 12510081 | 1 | Back pain |
| 125100812 | 12510081 | 2 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125100812 | 12510081 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125100812 | 12510081 | Cushing's syndrome | |
| 125100812 | 12510081 | Drug interaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |